Solid biosciences to provide update on long-term outcomes data from patients in the ongoing ignite dmd phase i/ii clinical trial of sgt-001

- functional and patient-reported outcomes data for the first three patients in the high-dose (2e14 vg/kg) cohort (patients 4-6) 1.5 years post-dosing to be presented at the world muscle society 2021 virtual congress -

SLDB Ratings Summary

SLDB Quant Ranking